“The study is expected to be completed in the first quarter of next year according to clinicaltrials.gov and could provide ...

The sNDA was submitted to support full approval of OCA for this indication based on data from the COBALT trial, as well as real-world evidence.

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into a technology ...

Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics ...

To learn more about these trials please visit ClinicalTrials.gov. This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 ...

New treatments and advances in cancer research are constantly emerging data from ClinicalTrials.gov shows that there are currently more than 32,000 active cancer studies. Nearly twenty-five percent of ...

Detailed price information for Legend Biotech Corp ADR (LEGN-Q) from The Globe and Mail including charting and trades.

Treatment with IV secukinumab led to rapid improvements in the signs and symptoms of PsA, which were maintained through 52 weeks.

Syros Pharmaceuticals announced that its phase 3 trial of tamibarotene in combination with azacitidine did not meet the primary endpoint for the treatment of myelodysplastic syndrome.

Anebulo announced it has been awarded the first tranche of a two-year cooperative grant of up to approximately $1.9 million from the National Institute on Drug Abuse ("NIDA"), part of the National ...